Charlotte Spicer is a Volunteer Writer at BioNews, having originally joined the publication under the auspices of its writing scheme. She is currently working as a postdoctoral researcher at University College London's Queen Square Institute of Neurology, investigating a gene therapy approach for the rare neurodegenerative disorder spinal bulbar muscular atrophy (also known as Kennedy's disease). Previously, she studied Neuroscience at the University of Leeds, with a year’s industrial experience with the London Pain Consortium at Imperial College London. After this she undertook a PhD in which she investigated the effects of upregulating the heat shock response in models of a rare muscle-wasting disease called inclusion body myositis. This was conducted under the the supervision of Professor Linda Greensmith and funded by the Medical Research Council's Centre for Neuromuscular Diseases at UCL.
Scientists have directly delivered proteins to mouse testes for the first time, in an attempt to treat male infertility...
A small fragment of genetic code inherited from Neanderthals may increase the risk of severe illness from COVID-19...
A transgender couple have announced the birth of their first child...
A team of researchers in the US has become the first to use the genome-editing tool CRISPR directly on a person's body...
A gene therapy trial for Duchenne muscular dystrophy (DMD) has been halted after a patient experienced serious side effects...
Chinese scientists have used the genome editing tool CRISPR in an attempt to treat HIV in a patient with blood cancer, for the first time...
The first RNA-based therapy has been approved for NHS use in England...
UK scientists have used genome-editing to identify hundreds of potential drug targets for new cancer treatments...
A second pregnancy established with a genome-edited embryo is ongoing, Chinese authorities have confirmed...
Scientists have successfully used genome editing in the kidneys of mice for the first time...
